Loading clinical trials...
Loading clinical trials...
The primary purpose of this study is to determine whether or not varenicline will help people with cardiovascular disease quit smoking and to confirm it is safe in these patients.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT07129590 · Smoking Cessation, Tobacco Smoking, and more
NCT06598397 · Human Immunodeficiency Virus (HIV), Smoking Cessation
NCT07441928 · Smoking Cessation, Schizophenia Disorder
NCT07080788 · Smoking Cessation Intervention, Pain, and more
NCT05846841 · Physician's Role, Smoking Cessation, and more
Pfizer Investigational Site
Hartford, Connecticut
Pfizer Investigational Site
Boston, Massachusetts
Pfizer Investigational Site
Madison, Wisconsin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions